← Back to directory

Allen Cheng

Researcher Next ID · RN-033357

Researcher · Immunology and Microbiology

Australian Regenerative Medicine Institute

Clayton, Australia

Accepting doctoral researchersFunding unknown
Works count
921
Citation count
40,871
H-index
93
i10-index
448

Research interests

Immunology and Microbiology
Medicine
Influenza Virus Research Studies
Respiratory viral infections research
Antibiotic Use and Resistance
Burkholderia infections and melioidosis
Antimicrobial Resistance in Staphylococcus

Publications

  • Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

    Journal for ImmunoTherapy of Cancer · 2021 · 10.1136/jitc-2021-002485

  • Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

    JAMA · 2020 · https://doi.org/10.1001/jama.2020.12839

  • Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

    JAMA · 2020 · https://doi.org/10.1001/jama.2020.12839

  • A minimal common outcome measure set for COVID-19 clinical research

    The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30483-7

  • A serological assay to detect SARS-CoV-2 seroconversion in humans

    Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-0913-5

  • Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

    JAMA · 2020 · https://doi.org/10.1001/jama.2020.17022

  • The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design

    Annals of the American Thoracic Society · 2020 · https://doi.org/10.1513/annalsats.202003-192sd

  • Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020

    Eurosurveillance · 2020 · 10.2807/1560-7917.es.2020.25.47.2001847

  • Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

    JAMA · 2020 · 10.1001/jama.2020.0103

  • Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype

    Proceedings of the National Academy of Sciences · 2020 · https://doi.org/10.1073/pnas.2015486117

  • Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

    Nature Immunology · 2019 · 10.1038/s41590-019-0320-6

  • Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

    The Lancet Global Health · 2018 · https://doi.org/10.1016/s2214-109x(18)30186-4

  • 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

    Clinical Infectious Diseases · 2017 · 10.1093/cid/cix669

  • 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea

    Clinical Infectious Diseases · 2017 · 10.1093/cid/cix959

  • A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail

    The Lancet Infectious Diseases · 2016 · https://doi.org/10.1016/s1473-3099(16)30386-3

  • Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study

    Critical Care · 2013 · 10.1186/cc12681

  • Microbiological Aetiology, Epidemiology, and Clinical Profile of Prosthetic Joint Infections: Are Current Antibiotic Prophylaxis Guidelines Effective?

    Antimicrobial Agents and Chemotherapy · 2012 · 10.1128/aac.06246-11

  • Control of Fluoroquinolone Resistance through Successful Regulation, Australia

    Emerging infectious diseases · 2012 · 10.3201/eid1809.111515

  • Workshop on Treatment of and Postexposure Prophylaxis forBurkholderia pseudomalleiandB. malleiInfection, 2010

    Emerging infectious diseases · 2012 · 10.3201/eid1812.120638

  • Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity

    Internal Medicine Journal · 2011 · 10.1111/j.1445-5994.2011.02452.x

  • The Epidemiology and Clinical Spectrum of Melioidosis: 540 Cases from the 20 Year Darwin Prospective Study

    PLoS neglected tropical diseases · 2010 · https://doi.org/10.1371/journal.pntd.0000900

  • Defining the True Sensitivity of Culture for the Diagnosis of Melioidosis Using Bayesian Latent Class Models

    PLoS ONE · 2010 · https://doi.org/10.1371/journal.pone.0012485

  • The global distribution of Burkholderia pseudomallei and melioidosis: an update

    Transactions of the Royal Society of Tropical Medicine and Hygiene · 2008 · https://doi.org/10.1016/s0035-9203(08)70002-6

  • Melioidosis: Epidemiology, Pathophysiology, and Management

    Clinical Microbiology Reviews · 2005 · https://doi.org/10.1128/cmr.18.2.383-416.2005

  • Clinical Identifiers of Complicated Staphylococcus aureus Bacteremia

    Archives of Internal Medicine · 2003 · 10.1001/archinte.163.17.2066

Current projects

    No projects listed.